Hans, Didier http://orcid.org/0000-0003-1826-5958
Shevroja, Enisa http://orcid.org/0000-0001-6338-2948
McDermott, Michele
Huang, Shuang
Kim, Min
McClung, Michael http://orcid.org/0000-0002-7827-0778
Funding for this research was provided by:
Amgen
University of Lausanne
Article History
Received: 28 February 2022
Accepted: 1 September 2022
First Online: 17 September 2022
Declarations
:
: The study complied with the principles of the Declaration of Helsinki. Institutional review boards and ethics committees approved the protocol and consent process. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Not applicable.
: Didier Hans is the co-owner of the TBS patent and has corresponding ownership shares and position at Medimaps group.Enisa Shevroja has no conflict of interest.Michael McClung received honorarium and consulting fees from Amgen.Michele McDermott is an employee and stockholder of Amgen.Shuang Huang is an employee and stockholder of Amgen.Min Kim is an employee and stockholder of Amgen.